TP53 and PPM1D mutations are predominantly mutated in leukocytes of patients who have undergone cancer treatment for solid tumours and display clonal haematopoiesis (Coombs et al., 2017), associating genotoxic stress with clonal selection. The gene discussed is TP53; the disease is cancer.